EVAXION BIOTECH A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.31 USD | +2.13% |
|
+5.12% | -37.14% |
| Apr. 17 | Evaxion Announces Phase 2 Clinical Trial Update | CI |
| Apr. 11 | European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading | MT |
Chart calendar Evaxion Biotech A/S
c66.YmVsHPHMmTmYRWEVmYh1fte2u9KQ9TcdxsgVFJOt-Sk.DzUKUcD00nrqAhNN9P4hBI2C7f_Jm3olqod-Q_rXoHkqHS1JkoX_Q84NAg~00638213074869a97047737a8592db26
Upcoming events on Evaxion Biotech A/S
Past events on Evaxion Biotech A/S
| 2024-04-16 09:00 am | Annual General Meeting |
| 2024-04-02 09:00 am | Q4 2023 Earnings Call |
| 2024-04-01 | World Vaccine Congress |
| 2024-03-27 07:30 am | Q4 2023 Earnings Release |
| 2024-03-19 09:00 am | R&D Day |
| 2024-03-06 | MarketsandMarkets Next-Gen Immuno-Oncology Conference |
| 2024-03-06 | Biomarker and Companion Diagnostics Conference |
| 2024-03-06 | H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference |
| 2024-03-05 | Biologics World Nordics Conference |
| 2024-02-27 | Sachs Associates European Life Sciences CEO Forum |
| 2024-02-26 | Sachs Associates European Healthtech CEO Forum - Panel |
| 2024-01-11 09:00 am | Extraordinary Shareholders Meeting |
| 2024-01-07 | J.P. Morgan Healthcare Conference |
| 2023-12-19 04:15 pm | Q3 2023 Earnings Release |
| 2023-12-09 05:30 pm | American Society of Hematology Meeting |
| 2023-12-09 05:30 pm | American Society of Hematology Meeting |
| 2023-11-13 | Bio Markers Europe Conference |
| 2023-11-08 | NextGen Omics Congress |
| 2023-11-08 11:30 am | Investor Meeting - Key Opinion Leader |
| 2023-11-05 | Bio-Europe Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 6,27 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -25,5 -26,0 1.96% | -24,6 -25,0 1.56% | -21,6 -22,0 1.9% | -10,6 |
|
EBIT Million USD | Released Forecast Spread | -10,9 | -16,6 -16,1 -3.18% | -25,8 -25,0 -3.16% | -25,3 -25,2 -0.37% | -22,2 -22,2 0.23% | -10,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -16,6 -16,1 -2.95% | -24,7 -24,6 -0.63% | -23,9 -23,0 -4.1% | -22,9 -22,8 -0.51% | -11,4 |
|
Net income Million USD | Released Forecast Spread | -11,2 | -15,0 -14,7 -2.18% | -24,5 -23,0 -6.81% | -23,2 -22,6 -2.52% | -22,1 -22,5 1.49% | -11,2 |
|
EPS USD | Released Forecast Spread | 0,00 | -9,70 -9,55 -1.57% | -12,6 -11,7 -7.69% | -9,80 -9,60 -2.08% | -0,81 -5,66 85.7% | -1,39 |
| Announcement Date | 22/10/20 | 06/04/21 | 22/03/22 | 27/04/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,72 -6,62 -16.66% | -6,40 -7,74 17.31% | -6,26 -7,17 12.74% | -6,08 -7,30 16.64% | -6,53 -6,52 -0.14% | -6,39 -5,59 -14.47% | -5,68 -5,73 0.88% | -5,76 -5,33 -8.06% | -4,36 -4,76 8.35% | -4,16 | -3,97 | -3,93 | -4,02 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,05 -6,43 -9.64% | -6,04 -7,06 14.45% | -4,95 -6,66 25.75% | -5,92 -5,82 -1.55% | -7,05 -6,10 -15.52% | -6,44 -5,84 -10.27% | -5,91 -5,73 -3.15% | -5,87 -5,43 -8.1% | -4,70 -4,81 2.32% | -4,31 | -4,12 | -4,08 | -4,17 |
|
Net income Million USD | Released Forecast Spread | -8,37 -6,45 -29.73% | -5,79 -7,44 22.15% | -4,77 -6,97 31.62% | -5,74 -6,58 12.81% | -6,87 -6,30 -9.1% | -6,24 -5,75 -8.63% | -5,68 -5,63 -1% | -5,68 -5,34 -6.37% | -4,52 -4,72 4.24% | -4,14 | -3,96 | -3,92 | -4,01 |
|
EPS USD | Released Forecast Spread | -3,90 -2,93 -32.95% | -2,50 -3,27 23.47% | -2,00 -3,00 33.33% | -2,40 -2,67 10% | -2,90 -2,63 -10.13% | -2,40 -2,40 0% | -2,10 -2,15 2.33% | -2,10 -1,95 -7.69% | -0,15 -1,60 90.63% | -0,56 | -0,50 | -0,51 | -0,52 |
| Announcement Date | 22/03/22 | 11/05/22 | 10/08/22 | 14/11/22 | 27/04/23 | 31/05/23 | 17/08/23 | 19/12/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for Evaxion Biotech A/S
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVAX Stock
- Calendar Evaxion Biotech A/S
